ADUS on Nasdaq
Addus HomeCare Corp
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Aveanna Healthcare Holdings, Inc., Chemed Corporation or AdaptHealth Corp., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
32.5%Gross margin3
9.7%Operating margin3
6.7%Net margin3
23.2%Revenue growth, 20253
8.8%Return on equity3
0.11×Debt to equity3
$103.8MFree cash flow3
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Personal Care brought in 77% of the revenue Addus HomeCare Corp broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Personal Care | $794.7M | $856.6M | $1.1B |
| Hospice | $207.2M | $228.2M | $262.5M |
| Home Health | $56.8M | $69.8M | $70.8M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue68¢$960.7M
- Other costs24¢$334.4M
- Income tax2¢$31.5M
- Profit7¢$95.9M
Out of $1.4B in revenue.3
Where each dollar of operating cash went, fiscal 2025
- Capital spending7¢$7.7M
- Kept or used elsewhere93¢$103.8M
Out of $111.5M of cash from operations.3
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net service revenues | $1.4B | $1.2B | $1.1B |
| Cost of service revenues | $960.7M | $779.6M | $718.8M |
| Gross profit | $461.9M | $375.0M | $339.9M |
| General and Administrative Expense | $306.8M | $258.8M | $234.8M |
| Depreciation and amortization | $16.4M | $13.5M | $14.1M |
| Total operating expenses | $323.3M | $272.3M | $248.9M |
| Operating income | $138.6M | $102.7M | $91.0M |
| Interest income | -$2.4M | -$4.4M | -$1.5M |
| Interest expense | $13.6M | $7.7M | $11.1M |
| Total interest expense, net | $11.2M | $3.3M | $9.6M |
| Income before income taxes | $127.4M | $99.4M | $81.3M |
| Income tax expense | $31.5M | $25.8M | $18.8M |
| Net income | $95.9M | $73.6M | $62.5M |
| Basic net income per share (in dollars per share) | $5.31 | $4.33 | $3.91 |
| Diluted net income per share (in dollars per share) | $5.22 | $4.23 | $3.83 |
| Basic (in shares) | 18.1M shares | 17.0M shares | 16.0M shares |
| Diluted (in shares) | 18.4M shares | 17.4M shares | 16.3M shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $81.6M | $98.9M | |
| Accounts receivable, net of allowances for credit losses | $151.7M | $122.9M | |
| Prepaid expenses and other current assets | $36.2M | $38.6M | |
| Total current assets | $269.5M | $260.4M | |
| Property and equipment, net of accumulated depreciation and amortization | $25.0M | $24.7M | |
| Goodwill | $996.7M | $970.6M | $663.0M |
| Intangibles, net of accumulated amortization | $102.4M | $109.6M | |
| Operating lease assets, net | $43.7M | $47.3M | |
| Total other assets | $1.1B | $1.1B | |
| Total assets | $1.4B | $1.4B | |
| Accounts payable | $16.8M | $27.2M | |
| Accrued payroll | $65.9M | $62.1M | |
| Accrued expenses | $28.2M | $29.0M | |
| Operating lease liabilities, current portion | $13.1M | $12.8M | |
| Government stimulus advances | $11.7M | $11.2M | |
| Accrued workers compensation insurance | $13.7M | $13.6M | |
| Total current liabilities | $149.5M | $155.9M | |
| Long-term debt, net of debt issuance costs | $121.0M | $218.4M | |
| Long-term operating lease liabilities | $37.3M | $41.9M | |
| Deferred income tax | $44.1M | $25.8M | |
| Other long-term liabilities | $235.0K | $125.0K | |
| Total long-term liabilities | $202.5M | $286.3M | |
| Total liabilities | $352.0M | $442.1M | |
| Common stock$.001 par value; 40,000 authorized and 18,518 and 18,148 shares issued and outstanding as of December 31, 2025 and 2024, respectively | $18.0K | $18.0K | |
| Additional paid-in capital | $612.9M | $594.0M | |
| Retained earnings | $472.3M | $376.4M | |
| Total stockholders equity | $1.1B | $970.5M | $706.7M |
| Total liabilities and stockholders equity | $1.4B | $1.4B | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in shares) | 40.0M shares | 40.0M shares | |
| Common stock, shares issued (in shares) | 18.5M shares | 18.1M shares | |
| Common stock, shares outstanding (in shares) | 18.5M shares | 18.1M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $95.9M | $73.6M | $62.5M |
| Depreciation and amortization | $16.4M | $13.5M | $14.1M |
| Deferred income taxes | $17.9M | $13.2M | $2.8M |
| Share-Based Payment Arrangement, Noncash Expense | $16.4M | $11.2M | $10.3M |
| Amortization of debt issuance costs under the credit facility | $1.3M | $1.1M | $860.0K |
| Additions / charges | $1.6M | $1.1M | $731.0K |
| Gain on disposal of assets | -$2.0K | -$13.0K | $0 |
| Impairment of operating lease assets | $0 | $5.0M | $13.0K |
| (Gain) loss on termination of operating leases | $21.0K | $42.0K | -$23.0K |
| Gain on divestiture of business | $0 | -$3.7M | $0 |
| Accounts receivable | -$26.6M | $22.1M | $15.7M |
| Prepaid expenses and other current assets | -$1.8M | -$19.1M | -$3.1M |
| Government stimulus advances | $460.0K | $5.5M | -$7.6M |
| Accounts payable | -$12.7M | -$1.9M | $2.0M |
| Accrued payroll | $3.2M | -$146.0K | $9.2M |
| Accrued expenses and other liabilities | -$633.0K | -$5.0M | $4.7M |
| Net cash provided by operating activities | $111.5M | $116.4M | $112.2M |
| Acquisition of businesses, net of cash acquired | -$31.6M | -$353.9M | -$109.8M |
| Purchases of property and equipment | -$7.7M | -$6.0M | -$9.5M |
| Proceeds received from disposal of assets | $15.0K | $29.0K | $15.0K |
| Proceeds received from previous acquisition | $2.9M | $0 | $0 |
| Proceeds received from divestiture of business | $3.8M | $5.4M | $0 |
| Net cash used in investing activities | -$32.5M | -$354.6M | -$119.2M |
| Proceeds from borrowings on revolver credit facility | $11.3M | $233.0M | $110.0M |
| Payments on revolver loan credit facility | -$110.0M | -$136.4M | -$118.5M |
| Proceeds from public offering | $0 | $175.6M | $0 |
| Payments for debt issuance costs under the credit facility | -$113.0K | -$3.4M | $0 |
| Cash received from exercise of stock options | $2.5M | $3.4M | $319.0K |
| Net cash (used in) provided by financing activities | -$96.3M | $272.3M | -$8.2M |
| Net change in cash | -$17.3M | $34.1M | -$15.2M |
| Cash paid for interest | $12.5M | $6.5M | $10.3M |
| Cash paid for income taxes | $12.6M | $26.3M | $15.0M |
| Leasehold improvements acquired through tenant allowances | $363.0K | $130.0K | $0 |
| Licensing fees included in Fixed assets | $0 | $0 | $4.0M |
Recent filings
- Sep 14, 20268-K
- Aug 17, 20263
- Aug 13, 20268-K
- Aug 4, 202610-Q
- Aug 3, 20268-K
- Jun 23, 20264
- Jun 11, 20264
- Jun 11, 20264
- Jun 11, 20264
- Jun 11, 20264
- Jun 11, 20264
- Jun 11, 20264
- Jun 11, 20264
- Jun 10, 20268-K
- May 22, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10